Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $76.86 USD
Change Today -0.76 / -0.98%
Volume 445.5K
CRL On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas F. Ackerman

Chief Financial Officer and Corporate Executive Vice President, Charles River Laboratories International, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 3 different industries.

See Board Relationships
60$2,871,115
As of Fiscal Year 2014

Background*

Mr. Thomas F. Ackerman, also known as Tom, has been the Chief Financial Officer of Charles River Laboratories, Inc. since 1996 and serves as its Corporate Executive Vice President. Mr. Ackerman is responsible for overseeing Accounting and Finance Department, as well as Charles River Laboratories International Inc.'s Information Technology Group and Investor Relations. Mr. Ackerman has been the Chief Financial Officer of Charles River Laboratories International Inc. since ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: 978-988-5665

Board Members Memberships*

2003-Present
Director and Member of Audit Committee

Education*

BA
University Of Massachusetts
BS
University Of Massachusetts

Other Affiliations*

Annual Compensation*

Salary$530,273
Total Annual Compensation$530,273

Stock Options*

Restricted Stock Awards$1,228,801
All Other Compensation$8,016
Exercised Options125,749
Exercised Options Value$2,219,277
Exercisable Options70,055
Exercisable Options Value$1,881,411
Unexercisable Options51,535
Unexercisable Options Value$977,413
Total Value of Options$5,078,101
Total Number of Options247,339

Total Compensation*

Total Annual Cash Compensation$1,129,874
Total Short Term Compensation$530,273
Other Long Term Compensation$1,236,817
Total Calculated Compensation$2,871,115
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $76.86 USD -0.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jacqueline M. Lemke Chief Executive Officer, President and Director
Bioanalytical Systems Inc.
$387.9K
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$883.3K
Colin Shannon Chairman, Chief Executive Officer and President
PRA Health Sciences, Inc.
$1.1M
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
--
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
38.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.